725 related articles for article (PubMed ID: 24780473)
1. The kidney and uremic toxin removal: glomerulus or tubule?
Masereeuw R; Mutsaers HA; Toyohara T; Abe T; Jhawar S; Sweet DH; Lowenstein J
Semin Nephrol; 2014 Mar; 34(2):191-208. PubMed ID: 24780473
[TBL] [Abstract][Full Text] [Related]
2. Disposition and clinical implications of protein-bound uremic toxins.
Jansen J; Jankowski J; Gajjala PR; Wetzels JFM; Masereeuw R
Clin Sci (Lond); 2017 Jul; 131(14):1631-1647. PubMed ID: 28667064
[TBL] [Abstract][Full Text] [Related]
3. The Dual Roles of Protein-Bound Solutes as Toxins and Signaling Molecules in Uremia.
Masereeuw R
Toxins (Basel); 2022 Jun; 14(6):. PubMed ID: 35737063
[TBL] [Abstract][Full Text] [Related]
4. Residual renal function: a paradigm shift.
Lowenstein J; Grantham JJ
Kidney Int; 2017 Mar; 91(3):561-565. PubMed ID: 28202171
[TBL] [Abstract][Full Text] [Related]
5. Roles of organic anion transporters in the progression of chronic renal failure.
Enomoto A; Niwa T
Ther Apher Dial; 2007 Oct; 11 Suppl 1():S27-31. PubMed ID: 17976081
[TBL] [Abstract][Full Text] [Related]
6. Handling of Drugs, Metabolites, and Uremic Toxins by Kidney Proximal Tubule Drug Transporters.
Nigam SK; Wu W; Bush KT; Hoenig MP; Blantz RC; Bhatnagar V
Clin J Am Soc Nephrol; 2015 Nov; 10(11):2039-49. PubMed ID: 26490509
[TBL] [Abstract][Full Text] [Related]
7. Key Role for the Organic Anion Transporters, OAT1 and OAT3, in the in vivo Handling of Uremic Toxins and Solutes.
Wu W; Bush KT; Nigam SK
Sci Rep; 2017 Jul; 7(1):4939. PubMed ID: 28694431
[TBL] [Abstract][Full Text] [Related]
8. Identification and Quantitative Assessment of Uremic Solutes as Inhibitors of Renal Organic Anion Transporters, OAT1 and OAT3.
Hsueh CH; Yoshida K; Zhao P; Meyer TW; Zhang L; Huang SM; Giacomini KM
Mol Pharm; 2016 Sep; 13(9):3130-40. PubMed ID: 27467266
[TBL] [Abstract][Full Text] [Related]
9. Gut-derived uremic toxin handling in vivo requires OAT-mediated tubular secretion in chronic kidney disease.
Bush KT; Singh P; Nigam SK
JCI Insight; 2020 Apr; 5(7):. PubMed ID: 32271169
[TBL] [Abstract][Full Text] [Related]
10. Organic anion transporters play an important role in the uptake of p-cresyl sulfate, a uremic toxin, in the kidney.
Miyamoto Y; Watanabe H; Noguchi T; Kotani S; Nakajima M; Kadowaki D; Otagiri M; Maruyama T
Nephrol Dial Transplant; 2011 Aug; 26(8):2498-502. PubMed ID: 21303967
[TBL] [Abstract][Full Text] [Related]
11. Harnessing transporters to clear uremic toxins.
Moe OW
J Am Soc Nephrol; 2009 Dec; 20(12):2483-4. PubMed ID: 19926890
[No Abstract] [Full Text] [Related]
12. Drugs Commonly Applied to Kidney Patients May Compromise Renal Tubular Uremic Toxins Excretion.
Mihaila SM; Faria J; Stefens MFJ; Stamatialis D; Verhaar MC; Gerritsen KGF; Masereeuw R
Toxins (Basel); 2020 Jun; 12(6):. PubMed ID: 32545617
[TBL] [Abstract][Full Text] [Related]
13. Association Between Kidney Clearance of Secretory Solutes and Cardiovascular Events: The Chronic Renal Insufficiency Cohort (CRIC) Study.
Chen Y; Zelnick LR; Huber MP; Wang K; Bansal N; Hoofnagle AN; Paranji RK; Heckbert SR; Weiss NS; Go AS; Hsu CY; Feldman HI; Waikar SS; Mehta RC; Srivastava A; Seliger SL; Lash JP; Porter AC; Raj DS; Kestenbaum BR;
Am J Kidney Dis; 2021 Aug; 78(2):226-235.e1. PubMed ID: 33421453
[TBL] [Abstract][Full Text] [Related]
14. Possible involvement of organic anion and cation transporters in renal excretion of xanthine derivatives, 3-methylxanthine and enprofylline.
Nadai M; Kato M; Yoshizumi H; Kimura M; Kurono S; Abe F; Saito H; Hasegawa T
Life Sci; 2007 Sep; 81(15):1175-82. PubMed ID: 17897683
[TBL] [Abstract][Full Text] [Related]
15. The Effect of Uremic Solutes on the Organic Cation Transporter 2.
Cheung KWK; Hsueh CH; Zhao P; Meyer TW; Zhang L; Huang SM; Giacomini KM
J Pharm Sci; 2017 Sep; 106(9):2551-2557. PubMed ID: 28483424
[TBL] [Abstract][Full Text] [Related]
16. Roles of organic anion/cation transporters at the blood-brain and blood-cerebrospinal fluid barriers involving uremic toxins.
Hosoya K; Tachikawa M
Clin Exp Nephrol; 2011 Aug; 15(4):478-85. PubMed ID: 21611756
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional regulation of organic anion transporting polypeptide SLCO4C1 as a new therapeutic modality to prevent chronic kidney disease.
Suzuki T; Toyohara T; Akiyama Y; Takeuchi Y; Mishima E; Suzuki C; Ito S; Soga T; Abe T
J Pharm Sci; 2011 Sep; 100(9):3696-707. PubMed ID: 21656517
[TBL] [Abstract][Full Text] [Related]
18. Proximal tubular efflux transporters involved in renal excretion of p-cresyl sulfate and p-cresyl glucuronide: Implications for chronic kidney disease pathophysiology.
Mutsaers HA; Caetano-Pinto P; Seegers AE; Dankers AC; van den Broek PH; Wetzels JF; van den Brand JA; van den Heuvel LP; Hoenderop JG; Wilmer MJ; Masereeuw R
Toxicol In Vitro; 2015 Oct; 29(7):1868-77. PubMed ID: 26216510
[TBL] [Abstract][Full Text] [Related]
19. Cellular and molecular aspects of drug transport in the kidney.
Inui KI; Masuda S; Saito H
Kidney Int; 2000 Sep; 58(3):944-58. PubMed ID: 10972658
[TBL] [Abstract][Full Text] [Related]
20. New therapeutic perspectives on protein-bound uremic toxins in chronic kidney disease.
Malyszko J
Expert Opin Ther Targets; 2014 Feb; 18(2):109-13. PubMed ID: 24283253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
